Stefanie Ganzer

578 total citations
9 papers, 461 citations indexed

About

Stefanie Ganzer is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Stefanie Ganzer has authored 9 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 6 papers in Psychiatry and Mental health and 1 paper in Molecular Biology. Recurrent topics in Stefanie Ganzer's work include Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Amino Acid Enzymes and Metabolism (1 paper). Stefanie Ganzer is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Amino Acid Enzymes and Metabolism (1 paper). Stefanie Ganzer collaborates with scholars based in Germany and France. Stefanie Ganzer's co-authors include Tomas Müller‐Thomsen, Ulrike Mann, Sönke Arlt, Dieter Naber, William J. Jagust, Michael W. Weiner, Norbert Schuff, Bruce Reed, Helena Chui and Dan Mungas and has published in prestigious journals such as Neurology, Biochemical and Biophysical Research Communications and Journal of Neural Transmission.

In The Last Decade

Stefanie Ganzer

9 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Ganzer Germany 9 284 195 115 56 54 9 461
Jeanette Günther United States 7 361 1.3× 229 1.2× 124 1.1× 28 0.5× 85 1.6× 14 604
Etsuko Oshima Japan 15 276 1.0× 183 0.9× 114 1.0× 36 0.6× 72 1.3× 33 635
Jason J. Hassenstab United States 12 278 1.0× 278 1.4× 144 1.3× 56 1.0× 76 1.4× 24 558
Julien Delrieu France 14 298 1.0× 246 1.3× 81 0.7× 33 0.6× 45 0.8× 45 533
Thomas Walch Austria 14 406 1.4× 132 0.7× 138 1.2× 77 1.4× 78 1.4× 15 781
V. Canonico Italy 9 212 0.7× 128 0.7× 71 0.6× 30 0.5× 60 1.1× 27 635
David Ames Australia 7 305 1.1× 236 1.2× 161 1.4× 85 1.5× 94 1.7× 10 597
Frederik W. Wilmink Netherlands 9 206 0.7× 114 0.6× 58 0.5× 52 0.9× 23 0.4× 13 587
Tomoko Okina Japan 10 251 0.9× 121 0.6× 173 1.5× 41 0.7× 58 1.1× 17 441
Johan Goeman Belgium 15 335 1.2× 239 1.2× 89 0.8× 20 0.4× 71 1.3× 21 580

Countries citing papers authored by Stefanie Ganzer

Since Specialization
Citations

This map shows the geographic impact of Stefanie Ganzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Ganzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Ganzer more than expected).

Fields of papers citing papers by Stefanie Ganzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Ganzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Ganzer. The network helps show where Stefanie Ganzer may publish in the future.

Co-authorship network of co-authors of Stefanie Ganzer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Ganzer. A scholar is included among the top collaborators of Stefanie Ganzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Ganzer. Stefanie Ganzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ganzer, Stefanie, et al.. (2005). Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau.. PubMed. 26(6). 696–8. 13 indexed citations
2.
Ganzer, Stefanie, et al.. (2005). The influence of smoking on plasma folate and lipoproteins in Alzheimer disease, mild cognitive impairment and depression.. PubMed. 26(3). 261–3. 9 indexed citations
3.
Müller‐Thomsen, Tomas, et al.. (2004). Detecting depression in Alzheimer?s disease: evaluation of four different scales. Archives of Clinical Neuropsychology. 20(2). 271–276. 133 indexed citations
4.
Du, Antao, Norbert Schuff, Joel H. Kramer, et al.. (2004). Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology. 62(3). 422–427. 160 indexed citations
5.
Ganzer, Stefanie, et al.. (2004). 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.. PubMed. 25(6). 435–7. 23 indexed citations
6.
Ganzer, Stefanie, Volker Schoder, Carsten Buhmann, et al.. (2003). CSF-tau, CSF-A�1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer?s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity. Journal of Neural Transmission. 110(10). 1149–1160. 36 indexed citations
7.
Müller‐Thomsen, Tomas, Sönke Arlt, Stefanie Ganzer, et al.. (2002). Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men. Dementia and Geriatric Cognitive Disorders. 14(2). 59–63. 31 indexed citations
8.
Streichert, Thomas, et al.. (2001). The Microbial Receptor CEACAM3 Is Linked to the Calprotectin Complex in Granulocytes. Biochemical and Biophysical Research Communications. 289(1). 191–197. 9 indexed citations
9.
Moritz, Steffen, et al.. (1999). Cognitive Dysfunction at Baseline Predicts Symptomatic 1-Year Outcome in First-Episode Schizophrenics. Psychopathology. 33(1). 48–51. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanette Günther Breakdown of academic impact, for papers by Etsuko Oshima Breakdown of academic impact, for papers by Jason J. Hassenstab Breakdown of academic impact, for papers by Julien Delrieu Breakdown of academic impact, for papers by Thomas Walch Breakdown of academic impact, for papers by V. Canonico Breakdown of academic impact, for papers by David Ames Breakdown of academic impact, for papers by Frederik W. Wilmink Breakdown of academic impact, for papers by Tomoko Okina Breakdown of academic impact, for papers by Johan Goeman
Rankless by CCL
2026